Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net loss from continuing operations	$ (1,431,713)	$ (1,505,867)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	145,927	114,829
Depreciation and amortization of intangible assets	15,038	23,952
Amortization of right of use assets	22,282	49,756
Change in fair value of earnout liabilities	(96,053)	0
Inventory write-down	196,684	0
Changes in operating assets and liabilities:
Accounts receivable	(12,165)	(14,102)
Inventory	31,376	15,204
Prepaid expenses	101,532	145,130
Accounts payable	551,354	317,040
Accrued expenses and other liabilities	15,112	149,392
Lease liability	(24,665)	(48,287)
Net cash used in operating activities	(485,291)	(752,953)
Cash flows from investing activities
Cash paid for Elevai Acquisition transaction costs		(150,000)
Net cash used in investing activities		(150,000)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of costs	190,001	1,637,610
Repayment of loans	(98,054)	(121,749)
Net cash provided by financing activities	91,947	1,515,861
Net (decrease) increase in cash and cash equivalents	(393,344)	612,908
Cash and cash equivalents - beginning of period	706,740	157,139
Cash and cash equivalents - end of period	313,396	770,047
Supplemental cash flow information:
Interest paid	3,450	4,993
Non-cash investing and financing activities:
Insurance premium financing agreements	23,457
Fair value of shares issued in Elevai Acquisition	$ 67,742	660,805
Consideration payable		67,742
Earnout liabilities in Elevai Acquisition		$ 301,633